• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

Trade Alert - (SPY) January 17, 2024 - BUY - INCREASE SHORT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-18 13:27:062024-01-18 13:27:06Trade Alert - (SPY) January 17, 2024 - BUY - INCREASE SHORT
april@madhedgefundtrader.com

January 18, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
January 18, 2024
Fiat Lux

Featured Trade:

(A WEIGHTY IMPACT)

(LLY), (NVO), (MRNA), (AAPL), (AMZN), (GOOGL), (MSFT), (META), (NVDA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-18 12:02:472024-01-18 15:41:56January 18, 2024
april@madhedgefundtrader.com

A Weighty Impact

Biotech Letter

Today, let's talk about something that's stirring up quite the buzz in the investment community, something that's not just about numbers and charts, but about potentially changing lives.

Now, I'm sure you've heard of Apple (AAPL), Amazon (AMZN), Alphabet (GOOGL), Microsoft (MSFT), Meta Platforms (META), and Nvidia (NVDA). These tech titans aren't just playing around with gadgets and gizmos; they're digging deep into the world of knowledge to uncover stuff we didn't even know was missing. And let's be clear, this isn't just some fancy artificial intelligence show-off; it's bigger, much bigger.

But, recently, other industries aren’t letting tech have all the fun.

The pharma industry, led by stars like Moderna (MRNA), Eli Lilly (LLY), and Novo Nordisk (NVO), is on the brink of what I'd call medical miracles.

We're looking at treatments that might kick some serious diseases to the curb – illnesses that we thought were just part of the unlucky draw in the genetic lottery.

Admittedly, figuring out the real worth of these innovations is a bit like trying to nail jelly to the wall – traditional financial analysis scratches its head at this sort of thing.

But for those of you who don't mind a bit of a rollercoaster ride, investing in these themes could be as rewarding as finding a forgotten winning lottery ticket in your old jeans.

Let's chew on obesity for a second. It's a big deal, literally and figuratively. It's the root of all sorts of nasty stuff like heart disease and diabetes.

Here's where Lilly and Novo Nordisk come in, swinging like heroes with their weight-loss drugs. These aren't just your average diet pills; we're talking about drugs that could turn the tables on major illnesses and even some curveballs like Alzheimer’s and sleep apnea.

Lilly's stock has been on a joyride, up 77% in the past year. Sure, by the bookworms' metrics, it's overvalued, but if you ask me, those numbers are playing catch-up to what these drugs could really do.

For context, imagine if you had bought Amazon or Apple back when they were just a bookstore and a computer company. Looking at their history and trajectory, Lilly and Novo Nordisk could be cooking up something similar.

And with over 20 studies lined up in the next five years, Lilly's stock, hanging around $625, could jump to a cool $840 by 2028 if things go well.

Keep in mind that the obesity treatment market is huge, and I mean, really huge. We're talking over 100 million potential customers in the U.S. alone.

And get this: insurance companies, those penny pinchers, are likely to cover these drugs because they're cheaper than surgeries.

Getting down to the specifics with Lilly, they've been making waves in the weight loss market with Mounjaro, raking in a sweet $2.9 billion in just nine months. And with Zepbound, it's like they've hit the jackpot twice.

Still, it's not a solo race; Novo Nordisk is right there with Wegovy and Ozempic. The demand is so hot that there were shortages last year. Talk about being in high demand!

But here's where Lilly might just have the upper hand. Their molecule, tirzepatide, is like the Usain Bolt of weight loss drugs – up to three times more effective than Novo Nordisk’s semaglutide.

And with the market expected to balloon to $100 billion by 2030, we're just seeing the opening act of what could be a blockbuster show.

With all this obesity talk, it’s important to understand that Lilly is no one-trick pony. They've got a whole stable of drugs treating everything from lymphoma to ulcerative colitis. And with over 20 programs in phase 3 studies, they're not running out of steam anytime soon.

Plus, here's the cherry on top: Lilly isn't just about making money; they're sharing the love with a 15% hike in their dividend.

That means if you jump on the Lilly train by Feb. 15, you're in for a treat in early March.

So, is Lilly a solid bet for the long haul? It sure looks like it. The excitement around their weight loss treatments is just one piece of the puzzle.

With a variety of drugs in their arsenal and an impressive pipeline, Lilly isn't just a flash in the pan. Sure, there are the usual hiccups like patent expiries and pipeline flops, but with their portfolio, they look set to weather any storms and keep the growth party going. I suggest you buy the dip.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-18 12:00:512024-01-18 15:41:39A Weighty Impact
april@madhedgefundtrader.com

Trade Alert - (NVDA) January 18, 2024 - TAKE PROFITS - SELL

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-18 11:55:262024-01-18 11:55:26Trade Alert - (NVDA) January 18, 2024 - TAKE PROFITS - SELL
april@madhedgefundtrader.com

January 18, 2024

Diary, Newsletter, Summary

Global Market Comments
January 18, 2024
Fiat Lux

Featured Trade:

(MY 20 RULES FOR TRADING IN 2024)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-18 09:04:442024-01-18 09:52:16January 18, 2024
april@madhedgefundtrader.com

My 20 Rules for Trading in 2024

Diary, Newsletter

Nothing like starting the new year by going back to basics and reviewing the rules that worked so well for us in 2023. Call this the refresher course for Trading 101.

I usually try to catch three or four trend changes a year, which might generate 100-200 trades and often come in frenzied bursts. In 2023, there were exactly two great entry points for stocks, the breakout of the regional banking crisis on March 15 and the peak fears of “higher for longer” on October 16.

Since I am one of the greatest tightwads that ever walked the planet, I only like to buy positions when we are at the height of despair and despondency, and traders are raining off the Golden Gate Bridge.

Similarly, I only like to sell when the markets are tripping on steroids and ecstasy and traders are convinced that they can live forever.

 

 

Some 99% of the time, the markets are in the middle, and there is nothing to do but do deep research and build shopping lists for the next trade. That is the purpose of this letter.

Over the five decades that I have been trading, I have learned a number of tried and true rules which have saved my bacon countless times. I will share them with you today.

1) Don’t over trade. This is the number one reason why individual investors lose money. Look at your trades of the past year and apply the 90/10 rule. Dump the least profitable 90% and watch your performance skyrocket. Then aim for that 10%. Over-trading is a great early retirement plan for your broker, not you.

2) Always use stops. Risk control is the measure of a good hedge fund trader. If you lose all your capital on the lemons, you can’t play when the great trades are set up. Consider cash as having an option value.

3) Don’t forget to sell. Date, don’t marry your positions. Remember, hogs get fed and pigs get slaughtered. My late mentor, Barton Biggs, told me to always leave the last 10% of a move for the next guy.

4) You don’t have to be a genius to play this game. If that was required, Wall Street would have run out of players a long time ago.

If you employ risk control and stop, then you can be wrong 40% of the time, and still make a living. That’s a little better than a coin toss. If you are wrong only 30% of the time, you can make millions.

If you are wrong a scant 20% of the time, you are heading a trading desk at Goldman Sachs. If you are wrong a scant 10% of the time, you are running a $20 billion hedge fund that the public only hears about when you pay $100 million for a pickled shark at a modern art auction.

If someone says they are never wrong, as is often claimed on the Internet, run a mile, because it is impossible. By the way, I was wrong 15% of the time in 2013. That’s what you’re paying for.

5) This is hard work. Trading attracts a lot of wide-eyed, naïve, but lazy people because it appears so easy from the outside. You buy a stock, watch it go up, and make money. How hard is that?

The reality is that successful investing requires twice as much work as a normal job. The more research you put into a trade, the more comfortable you will become, and the more profitable it will be. That’s what this letter is for.

6) Don’t chase the market. If you do, it will turn back and bite you. Wait for it to come to you. If you miss the train, there will be another one along in minutes, hours, days, weeks, or months. Patience is a virtue.

7) Limit Your Losses. When I put on a position, I calculate how much I am willing to lose to keep it. I then put a stop just below there. If I get triggered, I just walk away. Emotion never enters the equation.

Only enter a trade when the risk/ reward is in your favor. You can start at 3:1. That means only risk a dollar to potentially make three.

8) Don’t confuse a bull market with brilliance. I am not smart, just old as dirt.

9) Tape this quote from the great economist and early hedge fund trader of the 1930s, John Maynard Keynes, to your computer monitor: "Markets can remain illogical longer than you can remain solvent." Hang around long enough, and you will see this proven time and again (ten-year Treasuries at 1.38%?!).

10) Don’t believe the media. I know, I used to be one of them. Look for the hard data, the numbers, and you’ll see that often the talking heads, the paid industry apologists, and politicians don’t know what they are talking about (the Gulf oil spill will create a dead zone for decades?).

Average out all the public commentary, and half are bullish and half bearish at any given time. The problem is that they never tell you which one is right (that is my job). When they all go one way, the markets usually go in the opposite direction.

 

 

11) When you are running a long/short portfolio, 80% of your time is spent managing the shorts. If you don’t want to do the work, then cash beats a short any day of the week.

12) Sometimes the conventional wisdom is right.

13) Invest like a fundamentalist, and execute like a technical analyst. This is what all the pros do.

14) Use technical analysis only, and you will buy every rally, sell every dip, and end up broke. That said, learn what an “outside reversal” is, and who the hell is that Italian guy, Leonardo Fibonacci.

15) The simpler a market approach, the better it works. Everyone talks about “buy low and sell high”, but few do it. All black boxes eventually blow up, if they were ever there in the first place.

16) Markets are made up of people. Understand and anticipate how they think, and you will know what the markets are going to do.

17) Understand what information is in the market and what isn’t and you will make more money.

18) Do the hard trade, the one that everyone tells you that you are “Mad” to do. If you add a position and then throw up on your shoes afterward, then you know you’ve done the right thing. This is why people started calling me “Mad” 40 years ago. (What? Tech stocks were a huge buy the first week of January?).

19) If you are trying to get out of a hole, the first thing to do is quit digging and throw away the shovel. Sell everything. A blank position sheet can be invigorating and illuminating.

20) Making money in the market is an unnatural act, and fights against the tide of evolution.

We humans are predators and hunters evolved to track game on the horizon of an African savanna. Modern humans are maybe 5 million years old, but civilization has been around for only 10,000 years.

Our brains have not had time to make the adjustment. In the market, this means that if a stock has gone up, you believe it will continue to do so.

This is why market tops and bottoms see volume spikes. To make money, you have to go against these innate instincts.

Some people are born with this ability, while others can only learn it through decades of training. I am in the latter group.

 

Great Hunter, Lousy Trader

 

https://www.madhedgefundtrader.com/wp-content/uploads/2024/01/golden-gate-bridge.png 394 440 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-18 09:02:022024-01-18 09:52:11My 20 Rules for Trading in 2024
Douglas Davenport

AI ARMS RACE

Mad Hedge AI

(MSFT), (AAPL), (GOOGL), (DELL), (LNVGY)

In the high-octane world of tech titans, where the battle for supremacy unfolds with more gripping tension than the season finale of your favorite thriller, it's Microsoft (MSFT) and Apple (AAPL) that now find themselves at the epicenter.

As we stepped into January 2024, their battle for dominance has become the stuff of legends. Microsoft, with its towering $2.7 trillion market cap, is breathing down the neck of Apple's $2.8 trillion throne – the closest they've been since the autumn days of November 2021. 

This isn't just a numbers game; it's a clear sign that the winds in the tech world are shifting, and fast.

These behemoths, part of the elite club known as the "Magnificent Seven," don’t just move the market – they are the market. But even Titans can have off days. 

The first week of 2024 wasn’t exactly a walk in the park for Apple, grappling with a series of Wall Street downgrades. It seems their iPhone, once the crown jewel, is now showing signs of losing its sparkle amid softening sales. 

And let's not forget Apple's dance with China – a double-edged sword that brings both opportunities and headaches, thanks to the ongoing U.S.-China tensions and China's unpredictable economy.

Meanwhile, Microsoft is carving out its own narrative, and it’s one that’s AI-centric. 

By embracing ChatGPT and backing OpenAI, Microsoft is betting big on AI – and it's a bet that's starting to look like a masterstroke. 

In fact, the year 2024 is shaping up to be a banner year for them, thanks in no small part to this AI-driven strategy. 

The cloud computing arena, where Microsoft is elbowing its way against the likes of Google (GOOGL), is ballooning at an astonishing rate. 

From $546.1 billion in 2022 to a projected $2.3 trillion by 2032 – that’s not just growth; it’s practically an economic explosion. And Microsoft, with its AI prowess, is poised to stake a significant claim.

But let's cut through the hype for a moment. Microsoft's AI journey isn’t a smooth sail – it's a trek through uncharted waters. 

The company's use of AI has already landed them in legal hot water, with The New York Times raising the flag over alleged content misuse. Yet, despite these choppy waters, Wall Street's optimism hasn’t waned. Companies like Microsoft seem to have the grit to navigate these challenges, possibly through strategies like data licensing agreements.

The AI commitment from Microsoft is crystal clear, especially with the buzz around Sam Altman's rumored transition from OpenAI to Microsoft. It’s a move that signals their resolve to not just participate in the AI revolution but to lead it. 

Enter the AI key on Microsoft’s keyboards – a nod to the future that’s as bold as it was when they introduced the Windows key back in 1994. This isn’t just a new button; it’s a gateway to Microsoft's Copilot AI software on PCs running Windows 11. 

Forget the memories of Clippy; this is a whole new ballgame. The 365 Copilot, tagged at $30 per user a month, is already turning heads in its early corporate trials, promising to redefine productivity.

By 2026, this suite could be looking at $9.1 billion in incremental revenue. Based on Microsoft’s plans, Copilot is set to become an indispensable AI companion, both in the office and beyond. 

For context, the productivity apps market is on a trajectory to jump from $9.42 billion in 2022 to a whopping $15.97 billion by 2028.

The AI key might seem small, but it’s a giant leap in tech evolution. We’re talking about companies like Dell Technologies (DELL) and Lenovo Group (LNVGY) racing to launch PCs that can run generative AI applications independently, no internet needed. 

Microsoft’s vision of an OS that blends local and cloud processing is taking shape, and these AI-powered keyboards are expected to be the showstoppers with various Windows 11 PCs, including the Surface line, hitting the shelves starting in late February.

Over at Apple, CEO Tim Cook is acutely aware of the AI wave. Yet, he’s playing his cards close to the vest. With Microsoft’s relentless push into AI, Apple needs to reveal its hand soon if it wants to stay ahead in this relentless tech race.

https://www.madhedgefundtrader.com/wp-content/uploads/2024/01/Screenshot-2024-01-17-172722.jpg 742 739 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2024-01-17 17:29:202024-01-17 17:29:20AI ARMS RACE
april@madhedgefundtrader.com

Trade Alert - (SPY) January 17, 2024 - BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-17 14:08:502024-01-17 14:08:50Trade Alert - (SPY) January 17, 2024 - BUY
april@madhedgefundtrader.com

January 17, 2024

Tech Letter

Mad Hedge Technology Letter
January 17, 2024
Fiat Lux

Featured Trade:

(GROW WITH CROWDSTRIKE)
(CRWD), (NVDA)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-17 14:04:502024-01-17 16:23:09January 17, 2024
april@madhedgefundtrader.com

Grow With Crowdstrike

Tech Letter

CrowdStrike (CRWD) is expensive by any metric, but so are other tech stocks like Nvidia (NVDA).

The trajectory of the stock still looks bright. 

The cybersecurity company truly dishes out impressive growth numbers.

They are expected to grow sales by 39% over the next year and growth remains voluminous with no headwinds appear in the short term.

I’d be foolish not to mention one of the largest tailwinds in the tech sector in the form of defending and deterring digital malicious actors.

It’s real and capital is being allocated towards it.

The global cost of cybercrime is expected to double by 2028.

Sporting a market capitalization of $68 billion, CrowdStrike would need annualized returns of 18% to reach the $1 trillion club by 2040.

What do they mainly do?

Sifting through trillions of data points every week, CrowdStrike's single-agent, cloud-based cybersecurity platform grows more robust for each additional customer that joins its platform.

Quickly expanding its solutions from focusing primarily on endpoint protection (think laptops, printers, and servers) to becoming a complete security platform, CrowdStrike has grown from three security modules in 2016 to 27 today.

Each module provides a unique security solution and can be added by customers to fit their specific needs - all by relying upon just one agent, CrowdStrike's Falcon platform. The average number of agents on an endpoint today is 13 or more, so CrowdStrike's platform offers much-needed vendor consolidation for businesses looking to simplify their operations.

CrowdStrike is gradually becoming a one-stop shop for businesses' cybersecurity needs. Its growth potential and optionality seem almost boundless as it releases new modules tailor-made for its customers' desires. Look no further than two of its recent module advancements, each highlighting the company's ongoing shift toward becoming a complete security platform:

Falcon ID: CrowdStrike's identity protection and detection modules could become the company's next massive growth outlet. With 80% of global attacks stemming from exploited IDs, sales for these solutions grew from $7 million in annual recurring revenue (ARR) in Q3 of 2021 to over $200 million in Q2 of 2024.

Falcon Cloud: Bolstered by its recent acquisition of Bionic, which focuses on identifying and protecting items in the cloud, CrowdStrike now offers a complete cloud security solution. Growing its ARR from $106 million in Q4 of 2022 to nearly $300 million today, this cloud unit operates in a market expected to be worth over $32 billion by 2028.

Crowdstrike also landed an eight-figure deal from the federal government in its latest quarter. It counts less than 1% of the public sector as customers, so deals like this ignite a juicy channel of new revenue.

Thanks partly to its land-and-expand business model, CrowdStrike sees increasing profit margins for each additional module it sells to existing clients and each new customer it adds.

Who doesn’t like accelerating revenue and hypergrowth?

That’s what you get from CRWD.

The stock has been in overdrive pushing to new heights so I wouldn’t chase it right here.

It was only 365 days ago that the stock was at $101 and just touched $283.

That extraordinary rise is not the norm but is common with hyper-growth stocks.

It’s time to take the foot off the pedal and wait for a large dip which I do believe we will get.

That will be the next buying opportunity around $240 per share for CRWD.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-01-17 14:02:492024-01-17 16:23:05Grow With Crowdstrike
Page 7 of 15«‹56789›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top